Position in ABBV
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$891,057
+$137,672 QoQ
Shares Held
3,541
+2.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.85%
of 13F equity value
Holder Rank
#2,652
of 4,153 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 14%
Shared 0%
None 86%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Warren Street Wealth Advisors, LLC holds $18,220,871 across 7 Drug Manufacturers - General names. ABBV ranks #4 (4.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
29,570 | $7,509,892 | |
| 2 | AMGN |
Amgen Inc
|
20,698 | $7,495,159 | |
| 3 | LLY |
ELI LILLY & Co
|
1,197 | $1,435,717 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
3,541 | $891,057 | |
| 5 | MRK |
Merck & Co., Inc.
|
3,201 | $411,328 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,119 | $267,714 | |
| 7 | NVS |
Novartis AG
|
1,340 | $210,004 |
All Filings in ABBV
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $891,057 | 3,541 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $753,385 | 3,464 | Shares | Sole | 2026-04-16 | |
| 2025-12-31 | $772,981 | 3,383 | Shares | Sole | 2026-01-29 | |
| 2025-09-30 | $841,416 | 3,634 | Shares | Sole | 2025-10-17 | |
| 2025-06-30 | $642,245 | 3,460 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $736,043 | 3,513 | Shares | Sole | 2025-04-10 | |
| 2024-12-31 | $540,918 | 3,044 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $402,464 | 2,038 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $316,625 | 1,846 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $298,644 | 1,640 | Shares | Sole | 2024-04-30 | |
| 2023-12-31 | $237,569 | 1,533 | Shares | Sole | 2024-03-19 | |
| No filing history on record for this holder in this stock. | ||||||